ADAG - Adagene reports 1H results
2023-08-31 12:03:53 ET
More on Adagene ADR
- Adagene adds 12% on clinical trial collaboration with Roche
- Adagene, Merck gets FDA clearance to advance ADG126/Keytruda combo in solid tumor study
- Sanofi in multi-billion-dollar deal with Adagene for immuno-oncology candidates
- Dosing underway in Adagene's ADG106 + ADG116 study in solid tumors
- Seeking Alpha’s Quant Rating on Adagene ADR
- Earnings data for Adagene ADR
For further details see:
Adagene reports 1H results